SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000928475-05-000179
Filing Date
2005-07-21
Accepted
2005-07-21 17:09:52
Documents
1
Group Members
TRANSKARYOTIC THERAPIES INC

Document Format Files

Seq Description Document Type Size
1 transkaryoticschedule13d7-21.txt SC 13D 39404
  Complete submission text file 0000928475-05-000179.txt   41453
Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02139 6173490200
TRANSKARYOTIC THERAPIES INC (Subject) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-47221 | Film No.: 05966904
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ICAHN ASSOCIATES CORP 767 FIFTH AVE #4700 NEW YORK NY 10153
Business Address C/O ICAHN ASSOCIATES CORP 767 FIFTH AVE #4700 NEW YORK NY 10153 2127024300
ICAHN CARL C ET AL (Filed by) CIK: 0000921669 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13D
SIC: 0000